Publication: Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis
dc.contributor.author | Marcellin, Patric | |
dc.contributor.author | Buti, Maria | |
dc.contributor.author | Krastev, Zahary | |
dc.contributor.author | Di Bisceglie, Adrian M. | |
dc.contributor.author | Odin, Joseph A. | |
dc.contributor.author | Dusheiko, Geoffrey | |
dc.contributor.author | Heathcote, E. Jenny | |
dc.contributor.author | E. Jenny, Katyna | |
dc.contributor.author | Coombs, Derek | |
dc.contributor.author | Mondou, Elsa | |
dc.contributor.author | Anderson, Jane | |
dc.contributor.buuauthor | Gürel, Selim | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
dc.date.accessioned | 2022-09-15T07:21:36Z | |
dc.date.available | 2022-09-15T07:21:36Z | |
dc.date.issued | 2010-10 | |
dc.description | Bu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.citation | Marcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A. | en_US |
dc.identifier.endpage | 556A | tr_TR |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issue | 4, Supplement | en_US |
dc.identifier.startpage | 555A | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/28736 | |
dc.identifier.volume | 52 | tr_TR |
dc.identifier.wos | 000288775600481 | |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.title | Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | tr_TR |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: